ABSTRACT: Chronic ICV administration of NGF stimulates the activity of the cholinergic neuronal markers, HACU and ChAT, as well as the evoked release of both endogenous and newly synthesized acetylcholine in the brain of aging Fischer 344 male rats. However, the pattern of cholinergic phenotype stimulation indicates an age-related differential regulation of ChAT, HACU, and ACh release between specific brain areas, with the largest.effects found in the striatum. NGF treatment also increases the effectiveness of neurotransmission between basal forebrain cholinergic neurons and postsynaptic amygdaloid target neurons. The stimulation of central cholinergic transmitter function after NGF treatment affects behavior in a Y-maze brightness discrimination paradigm. NGF treatment does not affect the cognitive measure of brightness discrimination, but reduces the number of avoidance attempts, a measure of motor function. RESUME: Le NGF exogene influence la fonction de transmission cholinergique et le comportement de rats Fischer 344 males ages dans un labyrinthe en Y. L'administration chronique ICV de NGF stimule l'activite des marqueurs cholinergiques neuronaux, HACU et ChAT, ainsi que la liberation evoquee d'acetylcholine endogene et nouvellement synthetisee dans le cerveau de rats Fischer 344 males ages. Cependant, le profil de la stimulation ph6no-typique de nature cholinergique indique qu'il existe une regulation differentielle, reliee a l'age, de la liberation de ChAT, de HACU et de ACh entre des regions specifiques du cerveau, les effets les plus importants se retrouvant dans le striatum. Un traitement par le NGF augmente egalement l'efficacite de la transmission nerveuse entre les neurones cholinergiques de la base du prosencephale et les neurones cibles amygdaloides postsynaptiques. La stimulation de la fonction de transmission cholinergique centrale, apres traitement au NGF, influence le comportement dans le paradigme de discrimination lumineuse d'un labyrinthe en Y. Le traitement par le NGF n'influence pas la mesure cognitive de la discrimination lumineuse, mais diminue le nombre de tentatives d'evitement qui sont une mesure de la fonction motrice.
1
Of clinical interest is the role that NGF plays in the maintenance of the central cholinergic neurons in the basal forebrain and striatum. These neurons comprise three cholinergic systems: i) the projection neurons of the medial septum and diagonal band of Broca (MS/DB) to the hippocampus, ii) the projection neurons of the nucleus basalis magnocellularis (NBM) to the cerebral cortex and amygdala, and iii) the interneurons of the striatum (c.f., 2, 3). The neurons of all three systems are particularly affected by Alzheimer's disease where there is a pronounced loss in the levels of cortical and hippocampal acetylcholine (ACh), choline acetyltransferase (ChAT), and high affinity choline uptake (HACU). 4 . 5 In many Alzheimer's brains there is also evidence of substantial atrophy or death of cholinergic neurons in the MS/DB, NBM, and striatum. 46 Abnormalities in NGF metabolism have been hypothesized to underlie the cholinergic dystrophy associated with AD, 7 and the treatment of AD patients with NGF is currently being evaluated by the National Institute on Aging (NIA). 8 However, the neurotrophic role of NGF endogenous to the CNS is not well understood, and considerable work needs to be done to elucidate the effects of exogenous NGF on the transmitter function and behavior.
Using animal models, we are examining the age-related deficits in the central cholinergic systems, and the effects of exogenous NGF on cholinergic transmitter function. There is a differential age-related regulation of the cholinergic phenotypes expressed by the three major cholinergic neuronal systems, and their sensitivity to exogenous NGF. In aged rats, significant losses in ChAT activity are found in the MS/DB and striatum, but there is no apparent loss of enzyme activity in the NBM. 2 In THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES the frontal cortex and hippocampus of aged rats, there is a substantial loss of HACU, whereas in the striatum no HACU deficit is observed. 5 Intracerebroventricular (ICV) infusion of exogenous NGF into aged rats significantly increases ChAT and HACU in the hippocampus, frontal cortex, and striatum, with the largest stimulations found in the striatum. 5 We have extended these initial neurochemical findings to examine the effects of NGF on ACh release, cholinergic electrophysiology, and Ymaze behavior.
MATERIALS AND METHODS

ICV Cannula Implantation and NGF Solutions
Male Fischer 344 rats 4 to 24 months of age were obtained from the NIA colony at Harlan/Sprague-Dawley (Indianapolis, IN). Renin-free 2.5s NGF was purchased from Bioproducts for Science (Indianapolis, IN). Animals were anesthetized and implanted with a preformed cannula device, and infused with control and NGF solutions. 9 Animals were infused for two weeks using Model 2002 (0.5 nl/hr) Alzet osmotic pumps (Alza Corp., Palo Alto, CA) or four weeks using Model 2ML4 pumps (Y-maze) or paraffin-dipped 9 Model 2002 pumps (electrophysiology). The concentration of NGF was adjusted according to the particular pump flow rate so that the dose of NGF to the rat brain in all experiments was 1.2 (ig/day, a dose found to maximally stimulate basal forebrain ChAT activity in axotomized young adult Sprague-Dawley female rats. 3 Control animals were infused with the vehicle, the albumin (1 mg/ml) serving as a non-specific protein.
Analysis of ACh Release
At the end of 2 weeks of ICV vehicle or NGF infusion rats were decapitated, and the brains were quickly removed and rinsed in ice-cold buffered 0.32 M sucrose. Frontal cortex, hippocampus and striatum were dissected from the right hemisphere and then either prepared as slices for the chemiluminescent measurement of release of endogenous ACh, 10 or as synaptosomes for the measurement of release of newly-synthesized 3 H-ACh following preloading with 3 H-choline."
Electrophysiology
Conventional intracellular recordings were obtained from pyramidal cells in the basolateral amygdaloid (BLA) nucleus in vitro using 450 um slice preparations of ventral forebrain containing the amygdala prepared from 4 month old rats.
12 Glass microelectrodes filled with 2 M potassium acetate and having resistances of 90-160 MQ were used to impale single neurons identified as pyramidal cells by their characteristic discharge of a short burst of action potentials to a brief intracellular pulse of depolarizing current and by the presence of a prominent after hyperpolarization following a current evoked burst of spikes. To activate cholinergic afferents from basal forebrain to the BLA, 500 ms trains of stimuli were delivered via a stimulating electrode placed into the NBM, or by brief tetanic stimulation of the external capsule (EC). The ability of NBM or EC stimulation to elicit a slow muscarinic depolarization in BLA pyramidal neurons was assessed in slices from control (untreated and vehicletreated) and NGF-treated animals.
Y-Maze Brightness Discrimination Behavior
The effect of vehicle or NGF treatment on the behavior of 24-month-old rats was tested using the three-arm symmetrical Y-maze. 13 A series of nine 25-trial avoidance sessions began on the fifteenth day following NGF or vehicle treatment. Each session consisted of 25 trials separated by 40-sec inter-trial interval periods. Two response measures were used to describe the behavior: i) Percent Avoidance Attempts, the percentage of trials in a session in which at least one alley entry was made before shock (regardless of whether the movement was to the correct or incorrect alley); and ii) Percent Correct Discrimination, the percent of trials where the first entry, whether an avoidance or escape attempt, was to the correct alley.
RESULTS
NGF treatment stimulates release of both endogenous and newly synthesized ACh.
In 24-month-old rats, a substantial decrease in ChAT (31%) is measured in striatum, and HACU is decreased in frontal cortex (30%) and hippocampus (23%) compared to 4 month controls. 5 The age-related loss of striatal ChAT activity correlates with significant decrease (30%) in the evoked release of endogenous ACh in slices of striatum compared to 4 month controls (Figure 1 ). However, there was no decrease in the evoked release of newly synthesized 3 H-ACh from striatal synaptosomes. There also is no decrease in the release of ACh in aged frontal cortex or hippocampus by either method of measurement ( Figure 1) .
Treatment of aged rats with NGF for 2 weeks results in stimulations of ChAT activity in frontal cortex, hippocampus, and striatum, 30% compared to young controls. HACU activity in NGF-treated aged rats is increased in frontal cortex and striatum similar to ChAT, but there is no effect of NGF on HACU in the aged hippocampus. 5 The evoked release of endogenous ACh is increased only in the striatum of NGF-treated aged rats, 30% compared to control aged rats. However, the release of newly synthesized ACh is stimulated in all three brain regions after NGF infusion with the rank order of increase being striatum > frontal cortex > hippocampus (Figure 1 ).
NGF Increases Responsiveness of Amygdala Neurons to NBM Electrical Stimulation
The ability of NBM or EC stimulation to elicit a slow cholinergic depolarization was examined in 43 BLA pyramidal neurons in slices prepared from untreated (n=4) or vehicle-treated (n=4) 4 month old rats (Table 1 ). In the absence of eserine, depolarizing responses were recorded in 25% of the neurons after NBM stimulation and in 52% after activation of cholinergic fibres within the EC. In contrast, among the 33 neurons studied in slices from rats treated at least 3 weeks with NGF (n=8), 67% showed a cholinergic depolarization in response to NBM stimulation, and 80% responded to stimulation of the EC.
NGF Treatment Inhibits Y-Maze Avoidance Acquisition
After 15 days of treatment with vehicle or NGF at 1.2 |ig/day, 24 month old rats were tested in the Y-maze paradigm. The control group of animals quickly learned to avoid the shock by initiating more avoidance attempts (Figure 2 ) and by selecting the correct alley to enter (Figure 3 ). In the NGF-treated group, the avoidance movement was retarded in response to the light change (Figure 2) . The number of avoidance responses did not increase until near the end of experiment when the control animals already reached an asymptotic level of performance. In spite of a poorer movement initiation, the NGF treatment had no effect on the acquisition of brightness discrimination (Figure 3 ).
DISCUSSION
Infusion of NGF into the brain of rodents at a dose of 1.2 ug/day for two to four weeks has a profound stimulatory effect on the molecules regulating ACh synthesis, and the release of ACh from cholinergic nerve terminals. This stimulation of cholinergic transmitter metabolism correlates with the increased synaptic efficacy found in the NBM-amygdalopetal projection system after NGF treatment, and with inhibitory effects on animal behavior. The locomotor initiation necessary for shock avoidance response in the Y-maze was retarded while the acquisition of a brightness discrimination was unaffected.
The results indicate a differential age-related regulation of ChAT, HACU, and ACh release by the cholinergic neurons in the basal forebrain and striatum. In the frontal cortex and hippocampus of 24-month-old rats, there is a substantial loss of HACU but not ChAT, as compared to 4-month-old controls, whereas in the striatum there is a substantial loss of ChAT, but not HACU. 25 The decreases in the activities of these potentially rate limiting processes do not necessarily result in decreased presynaptic stores of ACh, as indicated by the measure of ACh evoked release. In fact, an age-related decrease in ACh release is only observed for endogenous ACh in the striatum (Figure 1 ). This decrease correlates with the significant loss of striatal ChAT activity. NGF treatment stimulates ChAT and HACU in both young and aged Fischer male rat brain, particularly in the striatum and frontal cortex. 5 However, the stimulation of these regulatory molecules does not correlate necessarily with a stimulation of ACh release using the administration protocol used in the present experiments. A stimulation of endogenous ACh release is only found in the aged striatum. NGF treatment stimulates the release of newly synthesized ACh in all three brain areas. The level of stimulation correlates more with the stimulation of ChAT activity than of HACU. The stimulation of cholinergic metabolism in the NBM projection system, as evidenced by the stimulation of newly synthesized ACh release in the frontal cortex, correlates with the increased synaptic efficacy found in the electrophysiologic experiments. After NGF treatment, there is a substantial increase (42%) in the number of amygdala pyramidal neurons responding to NBM electrical stimulation.
The stimulation of central cholinergic neurotransmission by NGF treatment might affect presumptive eholinergieally-mediated animal behaviors such as memory and extrapyramidal motor behaviors. NGF treatment at 0.12 ng/day (7s NGF) was reported to ameliorate age-related impairments in the Morris spatial memory maze.' 4 Similarly, treatment with 2.5s NGF at 0.3 |ig/day improved spatial memory performance in rats with NBM lesions. 15 In the Y-maze experiments, the aged rats were treated with 2.5s NGF at 1.2 |ig/day, the dose found to maximally stimulate ChAT activity. 3 At this dose, NGF had no effect on the presumed cognitive measure of brightness discrimination. However, the NGF treatment significantly reduced the rate of acquisition of the locomotor avoidance response. It is well recognized that cholinergic drugs affect the balance of extrapyramidal motor systems. In rats, scopolamine, the muscarinic antagonist causes an increase in avoidance responses or hyperactivity, while physostigmine, an acetylcholinesterase inhibitor which potentiates cholinergic transmission, results in a reduced number of avoidance responses or hypoactivity. 16 Thus, the effect of NGF treatment in reducing the number of avoidance responses in the Y-maze paradigm is very much in line with known cholinergic pharmacology. That is, NGF treatment probably stimulates striatal cholinergic interneuron synaptic efficacy resulting in an extrapyramidally-mediated hypoactivity in the Y-maze. The inability to demonstrate an enhancement in cognitive behavior after NGF treatment in the brightness discrimination task may be a limitation of the behavioral paradigm (e.g., the aged animals may not have been sufficiently impaired), or be related to the dose of NGF used in the experiment. A lower dose of NGF such as used in earlier experiments and a more cognitively demanding task (e.g. spatial memory) may shed further light on the functional significance of the cholinergic enhancement from NGF treatment. Cholinergic agonists can aggravate ataxia associated with AD. 17 Care must be taken if NGF is used to treat AD patients, 8 as consequential stimulation of cholinergic neurotransmission may exacerbate extrapyramidal symptoms.
